SINOMED(SH:688108) Ge Long Hui A P P·2026-01-30 08:38Core Viewpoint - Sino Medical (688108.SH) is expected to report a significant increase in net profit for the fiscal year 2025, with projections indicating a rise of 2,767% to 3,233% compared to the previous year [1] Financial Performance - The company anticipates a net profit attributable to shareholders ranging from 43 million to 50 million yuan, an increase of 41.5 million to 48.5 million yuan year-on-year [1] - The expected net profit after deducting non-recurring gains and losses is projected to be between 30 million and 35.8 million yuan, reflecting a year-on-year increase of 4.752 million to 5.332 million yuan, or 271% to 304% [1] Product Performance - Sales of balloon and stent products have significantly increased year-on-year, demonstrating the scale effect of the products [1] - The reduction in unit product costs has been substantial; however, the savings from lower unit costs are slightly outweighed by the cost increases associated with higher sales volumes, leading to a slight increase in operating costs year-on-year [1]